260 related articles for article (PubMed ID: 33742336)
1. Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience.
Sartori A; Dinoto A; Stragapede L; Mazzon G; Morelli ME; Pasquin F; Bratina A; Bosco A; Manganotti P
Neurol Sci; 2021 Dec; 42(12):5037-5043. PubMed ID: 33742336
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Nicholas J; Lublin F; Klineova S; Berwaerts J; Chinnapongse R; Checketts D; Javaid S; Steinerman JR
Mult Scler Relat Disord; 2023 Jul; 75():104745. PubMed ID: 37209500
[TBL] [Abstract][Full Text] [Related]
3. A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Patti F; Chisari CG; Fernández Ó; Sarroca J; Ferrer-Picón E; Hernández Vicente F; Vila Silván C
Eur J Neurol; 2022 Sep; 29(9):2744-2753. PubMed ID: 35590453
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap.
Chan A; Silván CV
Neurodegener Dis Manag; 2022 Jun; 12(3):141-154. PubMed ID: 35377770
[TBL] [Abstract][Full Text] [Related]
5. Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria.
Guger M; Hatschenberger R; Leutmezer F
Brain Behav; 2023 Apr; 13(4):e2947. PubMed ID: 36934456
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.
Ferrè L; Nuara A; Pavan G; Radaelli M; Moiola L; Rodegher M; Colombo B; Keller Sarmiento IJ; Martinelli V; Leocani L; Martinelli Boneschi F; Comi G; Esposito F
Neurol Sci; 2016 Feb; 37(2):235-42. PubMed ID: 26474875
[TBL] [Abstract][Full Text] [Related]
7. Effect of nabiximols on Goal Attainment Scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Paul F; Silván CV
Neurodegener Dis Manag; 2021 Apr; 11(2):143-153. PubMed ID: 33641348
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures.
Haupts MR; Essner U; Mäurer M
Neurodegener Dis Manag; 2024 Feb; 14(1):11-20. PubMed ID: 38318862
[TBL] [Abstract][Full Text] [Related]
9. Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study.
Baccouche I; Bensmail D; Leblong E; Fraudet B; Aymard C; Quintaine V; Pottier S; Lansaman T; Malot C; Gallien P; Levy J
Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136520
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis.
Carod-Artal FJ; Adjamian P; Vila Silván C; Bagul M; Gasperini C
Expert Rev Neurother; 2022 Jun; 22(6):499-511. PubMed ID: 35582858
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Nabiximols (Sativex
Carotenuto A; Costabile T; De Lucia M; Moccia M; Falco F; Petruzzo M; De Angelis M; Russo CV; Saccà F; Lanzillo R; Brescia Morra V
J Neurol; 2020 Jun; 267(6):1737-1743. PubMed ID: 32124041
[TBL] [Abstract][Full Text] [Related]
12. The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Grimaldi AE; De Giglio L; Haggiag S; Bianco A; Cortese A; Crisafulli SG; Monteleone F; Marfia G; Prosperini L; Galgani S; Mirabella M; Centonze D; Pozzilli C; Castelli L
PLoS One; 2019; 14(7):e0219670. PubMed ID: 31361750
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Riva N; Mora G; Sorarù G; Lunetta C; Ferraro OE; Falzone Y; Leocani L; Fazio R; Comola M; Comi G;
Lancet Neurol; 2019 Feb; 18(2):155-164. PubMed ID: 30554828
[TBL] [Abstract][Full Text] [Related]
14. Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.
De Blasiis P; Siani MF; Fullin A; Sansone M; Melone MAB; Sampaolo S; Signoriello E; Lus G
Mult Scler Relat Disord; 2021 Jun; 51():102805. PubMed ID: 33862313
[TBL] [Abstract][Full Text] [Related]
15. Cannabis and multiple sclerosis.
Fragoso YD; Carra A; Macias MA
Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
[TBL] [Abstract][Full Text] [Related]
16. Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.
Flachenecker P; Henze T; Zettl UK
Eur Neurol; 2014; 71(5-6):271-9. PubMed ID: 24525548
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Meuth SG; Henze T; Essner U; Trompke C; Vila Silván C
Int J Neurosci; 2020 Dec; 130(12):1199-1205. PubMed ID: 32065006
[No Abstract] [Full Text] [Related]
18. Effects of Sativex
Dykukha I; Essner U; Schreiber H; Raithel LM; Penner IK
Mult Scler Relat Disord; 2022 Dec; 68():104173. PubMed ID: 36174323
[TBL] [Abstract][Full Text] [Related]
19. The use of medical-grade cannabis in patients non-responders to Nabiximols.
Saccà F; Pane C; Carotenuto A; Massarelli M; Lanzillo R; Florio EB; Brescia Morra V
J Neurol Sci; 2016 Sep; 368():349-51. PubMed ID: 27538663
[No Abstract] [Full Text] [Related]
20. Treatment of spasticity with botulinum toxin.
O'Brien CF
Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
